Literature DB >> 16623431

Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant.

Luc Frimat1, Pierre-Yves Durand, Carole Loos-Ayav, Emmanuel Villar, Victor Panescu, Serge Briançon, Michèle Kessler.   

Abstract

BACKGROUND: We compared, in patients contraindicated for kidney transplant, outcomes between those patients who were only on hemodialysis (HD) and those who were given peritoneal dialysis (PD) as first renal replacement therapy (RRT).
DESIGN: Prospective, population-based cohort study of incident cases of end-stage renal disease between June 1997 and June 1999.
SETTING: A network of dialysis care: NEPHROLOR, that is, all the renal units in Lorraine, one of the 22 French administrative regions (population over 2.3 million people). PARTICIPANTS: 387 patients were contraindicated for kidney transplant during the first 2 years of RRT: 284 were on HD, 103 on PD. Mean age was 67.6 +/- 11.3 years for HD patients and 70.8 +/- 11.4 years for PD patients (p = 0.015). MAIN OUTCOME MEASURES: Mortality until June 2003, hospitalization over the 2 first years of RRT, and Kidney Disease and Quality of Life Short Form (KDQOL-SF) 6 and 12 months after initiation of RRT.
RESULTS: HD patients were more likely to die from cardiac or cerebrovascular causes, PD from cachexia or withdrawal from dialysis. Whatever mode of RRT, the unadjusted 2-year and 5-year survival rates were similar (p = 0.98). The rate of total duration of hospital stay per month of RRT was similarin HD and PD groups: 2.7 +/- 4.5 and 2.9 +/- 4.2 days respectively (p = 0.7). PD was associated with better quality of life than HD. The dimensions Role limitation due to emotional function, Burden of kidney disease, and Role limitation due to physical function ranked first, second, and third for PD.
CONCLUSION: In Lorraine, end-stage renal disease patients who were given PD as first-line RRT had no excess of death risk or hospitalizations, and better quality of life the first year of RRT.

Entities:  

Mesh:

Year:  2006        PMID: 16623431

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  7 in total

1.  Effectiveness of a day care program in supporting patients on peritoneal dialysis and their caregivers.

Authors:  Zhen Li Yu; Ying-Ying Seow; Pei Shing Seow; Ban Leong Kenny Tan
Journal:  Int Urol Nephrol       Date:  2016-02-22       Impact factor: 2.370

2.  Selection bias explains apparent differential mortality between dialysis modalities.

Authors:  Robert R Quinn; Janet E Hux; Matthew J Oliver; Peter C Austin; Marcello Tonelli; Andreas Laupacis
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 3.  A Comparison of Patient-Reported Outcome Measures of Quality of Life By Dialysis Modality in the Treatment of Kidney Failure: A Systematic Review.

Authors:  Brandon Budhram; Alison Sinclair; Paul Komenda; Melissa Severn; Manish M Sood
Journal:  Can J Kidney Health Dis       Date:  2020-10-19

4.  Changes in health-related quality of life in patients of self-care vs. in-center dialysis during the first year.

Authors:  Carole Loos-Ayav; Luc Frimat; Michèle Kessler; Jacques Chanliau; Pierre-Yves Durand; Serge Briançon
Journal:  Qual Life Res       Date:  2007-11-28       Impact factor: 4.147

5.  Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation.

Authors:  James G Heaf; Sonja Wehberg
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

6.  Better Quality of Life of Peritoneal Dialysis compared to Hemodialysis over a Two-year Period after Dialysis Initiation.

Authors:  Hee-Yeon Jung; Yena Jeon; Yeongwoo Park; Yon Su Kim; Shin-Wook Kang; Chul Woo Yang; Nam-Ho Kim; Ji-Young Choi; Jang-Hee Cho; Sun-Hee Park; Chan-Duck Kim; Yong-Lim Kim
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

Review 7.  A Global Overview of the Impact of Peritoneal Dialysis First or Favored Policies: An Opinion.

Authors:  Frank Xiaoqing Liu; Xin Gao; Gary Inglese; Piyatida Chuengsaman; Roberto Pecoits-Filho; Alex Yu
Journal:  Perit Dial Int       Date:  2014-07-31       Impact factor: 1.756

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.